Flamel Technologies, Inc

Latest News

April 25, 2008
Flamel Technologies Presents Results of Two Week Study of Interferon Alpha XL at the European Association for the Study of the Liver

March 4, 2008
Flamel Technologies Fourth Quarter and Year End 2007 Earnings Results Conference Call,
8:30 EST

March 3, 2008
Flamel Technologies Announces Fourth Quarter and Year-End Results; Fourth quarter includes strong clinical results; new agreements; and cash maintained at $41 million

March 3, 2008
Flamel Technologies Announces Nomination of Dr. Frank Fildes to Board of Directors; Flamel Technologies also announces departure of Michel Finance and appointment of Sian Crouzet

Medusa®

A Versatile Nano Carrier for the Delivery of Native Proteins

Medusa®, a self-assembled poly-aminoacid nanoparticles system, is a versatile protein carrier for the development of novel and second-generation long-acting native protein drugs. more info

Also available:
"Novel sustained release formulation of IFN-alfa-2b-XL, improves tolerability and demonstrates potent viral load reduction in a phase I/II HCV clinical trial" click here

"Novel Sustained Release Formulation of IL-2 Improves Pharmacokinetics Performance
and Demonstrates Potent Activation of Immunological Cell Line" click here

Micropump® Technologies

From Pediatric to Geriatric Uses

Controlled-release systems permitting either extended (Micropump® I) or both delayed and extended (Micropump® II) delivery of small molecule drugs.

more info

For more information about Flamel's drug delivery technologies, product development capabilities, and business partnerships, please contact:

In Europe

Stephen H. Willard
Chief Executive Officer
Phone: +33 (0) 472 783 434
Fax: +33 (0) 472 783 435
E-mail: willard@flamel.com

Rafael Jorda, Ph.D.
Vice President, Director of Manufacturing and Development
Phone: +33 (0) 472 783 434
Fax: +33 (0) 472 783 435
E-mail: jorda@flamel.com

In the USA

Nigel McWilliam,
Director, Business Development, USA
E-mail: mcwilliam@flamel.com

Office Locations

Headquarters
33 avenue du Dr. Georges Levy
69693 Venissieux Cedex
France
Phone: +33 (0) 472 783 434
Fax: +33 (0) 472 783 435

Manufacturing Facility
11 avenue Gustave Eiffel
33608 Pessac Cedex
France
Phone: +33 (0) 557 260 770
Fax: +33 (0) 556 365 891